Incidence of MRSA Higher in the U.S. Than in England

Article

Researchers from the Emerging Infections Program at the Centers for Disease Control and Prevention (CDC) and from the Health Protection Agency in England report on their comparison of the incidence of methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection (BSI) in the United States and England using population-based surveillance. Their research was published in the October issue of Clinical Infectious Diseases.

Lessa, et al. (2010) say that the incidence of community-onset MRSA BSI was 6.3-fold higher in the United States than in England, whereas the incidence of hospital-onset MRSA BSI was similar between the two countries.

Reference: Lessa FC, Mu Y, Davies J, Murray M, Lillie M, Pearson A and Fridkin SK. Comparison of Incidence of Bloodstream infection with methicillin-resistant Staphylococcus aureus between England and United States, 20062007. Clinical Infectious Diseases. 2010;51:925928

Recent Videos
Anna Castillo-Gutierrez, CRCST, CSPDT, CHL, CIS, CFER,  and Maya Luera, CRCST, CIS, CER, CHL
Lucy Witt, MD
Chase Elms, BS, CRCST
Garrett Hollembeak, CRCST, CIS, CHL, CER, CIC
Hannah Schroeder, BSHA, CRCST, CIS, CHL, CER,
Anthony Bondon CRCST, CHL, BSM, AAS, SME, LSSYB
Deannard Esnard, CRCST, CIS, CER, CHL, CFER, CQUIA
Kevin Bush, Jr, DHSc, EdD, MSHA, MA, MS, FACHE
Vatsala Rangachar Srinivasa, MPH
Related Content